Navigation Links
Flu Levels Starting to Fall, CDC Says
Date:2/11/2013

By Steven Reinberg
HealthDay Reporter

FRIDAY, Feb. 8 (HealthDay News) -- The flu seems to be easing its grip on the United States, federal health officials reported Friday.

While influenza activity remained elevated, it decreased in most areas of the country during the week ending Feb. 2, the U.S. Centers for Disease Control and Prevention reported.

According to the CDC:

  • Nineteen states experienced high levels of flu activity (Arizona, Arkansas, Colorado, Delaware, Hawaii, Illinois, Kansas, Louisiana, Michigan, Missouri, Nebraska, New Jersey, Oklahoma, Oregon, Texas, Utah, Vermont, Virginia and Wyoming).
  • Twelve states experienced moderate activity (Alabama, California, Connecticut, Idaho, Indiana, Minnesota, Mississippi, Nevada, New Mexico, North Dakota, West Virginia and Wisconsin).
  • Thirteen states experienced low activity (Alaska, Georgia, Iowa, Maryland, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Dakota, Tennessee and Washington).
  • And six states experienced minimal activity (Florida, Kentucky, Maine, Montana, New Hampshire and South Carolina).

The flu continued to hit older people hard, with more than 50 percent of hospitalizations involving adults 65 years and older.

Fifty-nine children have died from the flu this season, with 14 deaths reported last week, the CDC said.

There's no system to report adult deaths from flu, but the agency said the number of deaths remains higher than the threshold used to declare a flu epidemic.

The predominant strain of circulating flu this season continues to be influenza A H3N2, which typically poses bigger problems for young children and the elderly, according to the CDC. But, predominant strains can vary across states and regions of the country, the agency noted.

The 59 pediatric deaths so far compare to 153 deaths reported during the 2003-04 season, which was another H3N2 season, the agency said.

An estimated 36,000 people die from the flu and its complications in a typical season, according to the CDC. From 1976 to 2006, estimates of flu-associated deaths in the United States ranged from a low of about 3,000 to a high of about 49,000 people.

Flu season usually peaks in late January or early February.

The best defense against the flu remains the flu vaccine and it's not too late to get vaccinated, the CDC said. The agency recommends that everyone 6 months of age and older get vaccinated.

This year's vaccine appears to be well matched for the circulating flu strains, the CDC said. A recent report put the vaccine's effectiveness at 62 percent. No vaccine is 100 percent effective. But if flu strikes, vaccination often results in milder illness, the agency said.

Two antiviral medications, Tamiflu and Relenza, can reduce flu symptoms and the course of the disease. To be effective, however, they must be started within 48 hours after symptoms appear.

Flu symptoms include fever, cough, fatigue, head and body aches, and runny nose. People at particular risk for flu and its complications are pregnant women, those 65 and older and anyone with a chronic illness. The CDC urges these people to get the flu vaccine, which is available as an injection or nasal spray and in a stronger dose for seniors.

More information

For more on flu, visit the U.S. Centers for Disease Control and Prevention.

SOURCE: Feb. 8, 2013, U.S. Centers for Disease Control and Prevention, FluView


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Low vitamin D levels may increase risk of Type 1 diabetes
2. US Drug Watchdog Now Urges All DePuy ASR and Pinnacle Hip Implant Recipients to Get a Blood Test for Metals Levels and to Call Them for the Names of the Best Law Firms
3. Prescription overdose rate reaches epidemic levels in NYC
4. Men taking long-acting chronic pain meds 5xs more likely to have low testosterone levels
5. US Drug Watchdog Now Urges The All US Recipients of a Metal Hip Implant To Get A Blood Test For Metals Levels and They Offer To Help All Victims Get To The Best Law Firms
6. US Drug Watchdog Now Urges All DePuy Pinnacle Metal Hip Implant Recipients To Get A Blood Test for Cobalt and Chromium Levels Because Of Growing Worries Of Side Effects
7. Low-income pregnant women in rural areas experience high levels of stress, researcher says
8. US Drug Watchdog Now Urges All Metal Hip Implant Recipients to Get a Blood Test for Elevated Metals Levels Out of Fear of Side Effects Related to Cobalt or Chromium
9. Lead Levels Down in U.S. Kids, But Asthma Cases Rising: EPA
10. Flu Still at Epidemic Levels: CDC
11. Low vitamin D levels linked to high risk of premenopausal breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
(Date:5/26/2016)... Louis, Missouri (PRWEB) , ... May 26, 2016 ... ... cost, quality and clinical outcomes, hosted members and suppliers for its inaugural Member ... a focus on their mission of elevating the operational health of America’s healthcare ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... that has a significant negative impact on long-term patient survival, reports a team ... results, published online this week in the Journal of Thoracic and Cardiovascular Surgery, ...
(Date:5/26/2016)... ... , ... An April Gallup survey found rising health care costs to be ... Health Senior Living (SHSL) may not share those same worries thanks to a ... the year, while holding the line on increasing their contributions, including premiums, deductibles and ...
(Date:5/26/2016)... , ... May 26, 2016 , ... The Lung ... host a six-week smoking cessation class starting June 6 at their clinic in downtown ... http://www.gnahec.org . , Additionally, the Lung Institute has created a free downloadable 4 Week ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 ... 2016"market research report that provides an overview on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
(Date:5/24/2016)... , May 24, 2016 Celsion Corporation ... development company, today provided an update on its ... clinical trial combining GEN-1, the Company,s DNA-based immunotherapy, ... of newly-diagnosed patients with advanced ovarian cancer who ... surgery.  GEN-1 is an IL-12 DNA plasmid vector ...
Breaking Medicine Technology: